These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 27115761

  • 21. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
    Li S, Chen Q, Li H, Wu Y, Feng J, Yan Y.
    Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
    [Abstract] [Full Text] [Related]

  • 22. Quantified postsurgical small cell size CTCs and EpCAM+ circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse.
    Wang L, Li Y, Xu J, Zhang A, Wang X, Tang R, Zhang X, Yin H, Liu M, Wang DD, Lin PP, Shen L, Dong J.
    Cancer Lett; 2018 Jan 01; 412():99-107. PubMed ID: 29031565
    [Abstract] [Full Text] [Related]

  • 23. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM, Hou S, Winograd P, Segel NH, Li QW, Zhu Y, Sadeghi S, Finn RS, Ganapathy E, Song M, French SW, Naini BV, Sho S, Kaldas FM, Busuttil RW, Tomlinson JS, Tseng HR, Agopian VG.
    Liver Transpl; 2018 Jul 01; 24(7):946-960. PubMed ID: 29624843
    [Abstract] [Full Text] [Related]

  • 24. Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma.
    Takahashi K, Ofuji K, Hiramatsu K, Nosaka T, Naito T, Matsuda H, Endo K, Higuchi M, Ohtani M, Nemoto T, Nakamoto Y.
    Cancer Med; 2021 Apr 01; 10(7):2300-2309. PubMed ID: 33675149
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.
    Li TT, Liu H, Li FP, Hu YF, Mou TY, Lin T, Yu J, Zheng L, Li GX.
    World J Gastroenterol; 2015 Dec 21; 21(47):13259-67. PubMed ID: 26715808
    [Abstract] [Full Text] [Related]

  • 26. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W, Wan L, Wu S, Yang J, Zhou Y, Liu F, Wu Z, Cheng Y.
    Cell Oncol (Dordr); 2018 Oct 21; 41(5):495-504. PubMed ID: 29949050
    [Abstract] [Full Text] [Related]

  • 27. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J, Zhang Z, Zhou H, Leng C, Hou B, Zhou C, Hu X, Wang J, Chen X.
    BMC Cancer; 2020 Oct 31; 20(1):1047. PubMed ID: 33129301
    [Abstract] [Full Text] [Related]

  • 28. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells.
    Huaman J, Naidoo M, Zang X, Ogunwobi OO.
    Cells; 2019 Jun 20; 8(6):. PubMed ID: 31226820
    [Abstract] [Full Text] [Related]

  • 29. Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy.
    Xu W, Cao L, Chen L, Li J, Zhang XF, Qian HH, Kang XY, Zhang Y, Liao J, Shi LH, Yang YF, Wu MC, Yin ZF.
    Clin Cancer Res; 2011 Jun 01; 17(11):3783-93. PubMed ID: 21527564
    [Abstract] [Full Text] [Related]

  • 30. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
    Liu HY, Qian HH, Zhang XF, Li J, Yang X, Sun B, Ma JY, Chen L, Yin ZF.
    World J Gastroenterol; 2015 Mar 14; 21(10):2918-25. PubMed ID: 25780289
    [Abstract] [Full Text] [Related]

  • 31. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K, Gasch C, Staufer K, Nashan B, Lohse AW, Pantel K, Riethdorf S, Wege H.
    Int J Cancer; 2013 Nov 14; 133(9):2165-71. PubMed ID: 23616258
    [Abstract] [Full Text] [Related]

  • 32. Outcomes of anatomical versus non-anatomical resection for hepatocellular carcinoma according to circulating tumour-cell status.
    Qi LN, Ma L, Chen YY, Chen ZS, Zhong JH, Gong WF, Lu Y, Xiang BD, Li LQ.
    Ann Med; 2020 Nov 14; 52(1-2):21-31. PubMed ID: 31876201
    [Abstract] [Full Text] [Related]

  • 33. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
    Zhao L, Zheng Z, Liu Y, Liu F, Li X, Wu Z.
    J Cancer Res Clin Oncol; 2023 Aug 14; 149(9):6035-6048. PubMed ID: 36633681
    [Abstract] [Full Text] [Related]

  • 34. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
    Guo W, Yang XR, Sun YF, Shen MN, Ma XL, Wu J, Zhang CY, Zhou Y, Xu Y, Hu B, Zhang X, Zhou J, Fan J.
    Clin Cancer Res; 2014 Sep 15; 20(18):4794-805. PubMed ID: 25009297
    [Abstract] [Full Text] [Related]

  • 35. [Detection of circulating tumor cells in patients with hepatocellular carcinoma].
    Mu H, Lin K, Zhao H, Li C, Sun Y, Cai J, Zhao X.
    Zhonghua Zhong Liu Za Zhi; 2014 Apr 15; 36(4):276-81. PubMed ID: 24989914
    [Abstract] [Full Text] [Related]

  • 36. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA, Zekri AR, El-Bastawisy A, Fawzy A, Shetta M, Hussein N, Omran D, Ahmed AA, El-Labbody SS.
    World J Gastroenterol; 2014 Dec 28; 20(48):18240-8. PubMed ID: 25561791
    [Abstract] [Full Text] [Related]

  • 37. Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.
    Liu DG, Xue L, Li J, Yang Q, Peng JZ.
    Cancer Biomark; 2018 Dec 28; 22(3):417-426. PubMed ID: 29758927
    [Abstract] [Full Text] [Related]

  • 38. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
    Lowes LE, Allan AL.
    Adv Clin Chem; 2018 Dec 28; 83():121-181. PubMed ID: 29304900
    [Abstract] [Full Text] [Related]

  • 39. Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma.
    Bai T, Mai R, Ye J, Chen J, Qi L, Tang J, Wei M, Zhang L, Chen Z, Tang Z, Li L, Wu F.
    Transl Cancer Res; 2020 Mar 28; 9(3):1384-1394. PubMed ID: 35117486
    [Abstract] [Full Text] [Related]

  • 40. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.
    World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.